Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric Patzer currently holds 884,600 shares of Aridis Pharmaceuticals, Inc. (ARDS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Patzer has been a net buyer of ARDS stock. They have purchased $75.0K and sold $0 worth of shares.
Eric Patzer's most recent insider trade was on Jun 24, 2024, when they purchased 714,286 shares at $0.07 per share.
Eric Patzer serves as Executive at Aridis Pharmaceuticals, Inc. (ARDS). They have executed 4 insider transactions totaling $75.0K over their tenure at the company.
Eric Patzer holds the position of Executive at Aridis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Eric Patzer has shown a buying trading pattern, with $75.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Eric Patzer was on Jun 24, 2024, when they purchased $50.0K worth of ARDS shares. This transaction involved 714,286 shares at $0.07 per share.
Eric Patzer currently owns 884,600 shares of Aridis Pharmaceuticals, Inc. (ARDS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric Patzer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric Patzer has 4 Form 4 filings on record as an insider at Aridis Pharmaceuticals, Inc..
Set alerts for Eric Patzer and 40,000+ other insiders.